`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`______________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`______________
`
`MYLAN INSTITUTIONAL LLC,
`Petitioner,
`
`v.
`
`NOVO NORDISK A/S,
`Patent Owner.
`______________
`
`Case IPR2020-00324
`Patent 8,114,833
`______________
`
`
`PATENT OWNER’S EXHIBIT LIST
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Exhibit No.
`
`2001
`
`2002
`
`IPR2020-00324
`Pat. Owner’s Exhibit List
`
`EXHIBIT LIST
`
`Description
`
`Declaration of Ryan P. Johnson in Support of Petitioner Novo
`Nordisk A/S’s Unopposed Motion for Admission Pro Hace Vice of
`Ryan P. Johnson.
`
`Declaration of Laura T. Moran in Support of Petitioner Novo
`Nordisk A/S’s Unopposed Motion for Admission Pro Hace Vice of
`Laura T. Moran.
`
`
`
`1
`
`
`
`
`
`
`
`IPR2020-00324
`Pat. Owner’s Exhibit List
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. §§ 42.6 and 42.105, I hereby certify that the foregoing
`
`document was served on January 13, 2020, by filing this document through the
`
`Patent Trial and Appeal Board End to End System, as well as delivering a copy via
`
`electronic mail upon the following attorneys of record for the Petitioner:
`
`Brandon M. White
`Lara Dueppen
`Perkins Coie LLP
`white-ptab@perkinscoie.com
`dueppen-ptab@perkinscoie.com
`liraglutide@perkinscoie.com
`
`
`Date: January 13, 2020
`
`
`Respectfully submitted,
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`/ Jeffrey J. Oelke/
`Jeffrey J. Oelke (Reg. No. 37,409)
`
`Counsel for Novo Nordisk A/S
`
`
`
`
`
`2
`
`